Colorado Researchers Received Almost Half a Billion Dollars in 2020 NIH Grants

The University of Colorado Denver and the Anschutz Medical Campus received the majority of health research grants, including $1.8 million for projects specific to Covid-19. Find out more in the Denver...

Learn More

SomaLogic Appoints Jason Cleveland, Ph.D. as Chief Technology Officer

BOULDER, Colo. (January 8, 2021)—SomaLogic Inc., a global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, today announced the appointment of...

Learn More

DU scientists develop breakthrough COVID-19 antibody test

The test is so accurate, it can determine whether a person's symptoms will be mild or severe. DENVER — Scientists at the University of Denver's (DU) Knoebel Institute for Healthy Aging, in collaborati...

Learn More

Purdue partners with Colorado company to offer rapid testing for students ahead of spring 2021 semester

WEST LAFAYETTE, Ind. - Purdue University is partnering with a Colorado company led by a Purdue alum to offer rapid antigen COVID-19 testing for undergraduate, graduate and professional students t...

Learn More

SomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders

BOULDER, Colo., January 5, 2021 — SomaLogic Inc., a privately held health information company, announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice president for healthcare m...

Learn More

Bolder Surgical launches CoolSeal™ Vessel Sealing Platform

Expanding Bolder Surgical’s line of vessel sealing products LOUISVILLE, COLO., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Bolder Surgical, today announced the launch of its CoolSeal™ Vessel Sealing platform. ...

Learn More

Colorado Bioscience Companies Ramp Up Vaccine Development in 2021

Several Colorado companies are working on vaccines or technology to enhance vaccine distribution. Find out more in the Denver Business Journal article.

Learn More

SomaLogic Adds $81M to Series A Financing Totaling $214M

BOULDER, Colo., December 22, 2020 — SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81...

Learn More

Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

– Financing Round Led by Viking Global Investors – – Proceeds will fund ongoing clinical development of EDG-5506, a novel, oral drug candidate for Duchenne and Becker muscular dystrophy, as well as ot...

Learn More

SomaLogic Closes $121M Series A Financing Led by Casdin Capital

Capital raise will support expansion and commercialization of leading proteomics platform serving life science and clinical markets Syndicate of leading life science specialist investors BOULDER, Colo...

Learn More